dc.contributor.author | Johnson MS | |
dc.contributor.author | Ranga V | |
dc.contributor.author | Pirila L | |
dc.contributor.author | Heino J | |
dc.contributor.author | Jokinen J | |
dc.contributor.author | Sipila KH | |
dc.contributor.author | Mali M | |
dc.contributor.author | Rappu P | |
dc.contributor.author | Heino I | |
dc.contributor.author | Kapyla J | |
dc.date.accessioned | 2022-10-28T14:29:56Z | |
dc.date.available | 2022-10-28T14:29:56Z | |
dc.identifier.uri | https://www.utupub.fi/handle/10024/171718 | |
dc.description.abstract | We report the extent, specific sites and structural requirements of joint inflammation related citrullination in extracellular proteins. A total of 40 synovial fluid samples derived from chronically inflamed human joints were analysed by heparin-agarose fractionation and LC-MS/MS. Citrullination of 55 arginines in extracellular proteins was detected. Importantly, 20% of the sites have a characterized function related to the hallmarks of destructive joint inflammation. E.g. four arginine residues, shown here to be citrullinated, are also affected by mutations in inherited diseases causing haemolysis or blood clotting dysfunction. Citrullination of integrin ligands was selected for further studies since fibronectin R234 in isoDGR was among the most frequently citrullinated arginines in synovial fluid. Assays with synovial fibroblasts and integrin alpha V beta 3 indicated decreased affinity to the enzymatically citrullinated integrin binding sites. To conclude, our data indicate that in inflamed joints extensive citrullination affects the functional arginine residues in extracellular proteins. | |
dc.language.iso | en | |
dc.publisher | NATURE PUBLISHING GROUP | |
dc.title | Joint inflammation related citrullination of functional arginines in extracellular proteins | |
dc.identifier.urn | URN:NBN:fi-fe2021042717203 | |
dc.relation.volume | 7 | |
dc.contributor.organization | fi=PÄÄT Biokemia|en=PÄÄT Biochemistry| | |
dc.contributor.organization | fi=tyks, vsshp|en=tyks, vsshp| | |
dc.contributor.organization | fi=Turun biotiedekeskus|en=Turku Bioscience Centre| | |
dc.contributor.organization | fi=kliinisen laitoksen yhteiset|en=Department of Clinical Medicine| | |
dc.contributor.organization-code | 2609201 | |
dc.contributor.organization-code | 2606201 | |
dc.contributor.organization-code | 2607300 | |
dc.converis.publication-id | 26769324 | |
dc.converis.url | https://research.utu.fi/converis/portal/Publication/26769324 | |
dc.identifier.jour-issn | 2045-2322 | |
dc.okm.affiliatedauthor | Sipilä, Kalle | |
dc.okm.affiliatedauthor | Heino, Jyrki | |
dc.okm.affiliatedauthor | Pirilä, Laura | |
dc.okm.affiliatedauthor | Mali, Markku | |
dc.okm.affiliatedauthor | Rappu, Pekka | |
dc.okm.affiliatedauthor | Jokinen, Johanna | |
dc.okm.affiliatedauthor | Käpylä, Jarmo | |
dc.okm.affiliatedauthor | Dataimport, tyks, vsshp | |
dc.okm.affiliatedauthor | Heino, Ilona | |
dc.okm.discipline | 1182 Biokemia, solu- ja molekyylibiologia | fi_FI |
dc.okm.discipline | 1182 Biochemistry, cell and molecular biology | en_GB |
dc.okm.internationalcopublication | not an international co-publication | |
dc.okm.internationality | International publication | |
dc.okm.type | Journal article | |
dc.publisher.country | United Kingdom | en_GB |
dc.publisher.country | Britannia | fi_FI |
dc.publisher.country-code | GB | |
dc.relation.articlenumber | ARTN 8246 | |
dc.relation.doi | 10.1038/s41598-017-08597-4 | |
dc.relation.ispartofjournal | Scientific Reports | |
dc.year.issued | 2017 | |